MDT

100.05

+3%↑

A

146.51

+3.24%↑

VEEV

236.48

+6.28%↑

HQY

95.71

+1.86%↑

PHR.US

17.15

+0.06%↑

MDT

100.05

+3%↑

A

146.51

+3.24%↑

VEEV

236.48

+6.28%↑

HQY

95.71

+1.86%↑

PHR.US

17.15

+0.06%↑

MDT

100.05

+3%↑

A

146.51

+3.24%↑

VEEV

236.48

+6.28%↑

HQY

95.71

+1.86%↑

PHR.US

17.15

+0.06%↑

MDT

100.05

+3%↑

A

146.51

+3.24%↑

VEEV

236.48

+6.28%↑

HQY

95.71

+1.86%↑

PHR.US

17.15

+0.06%↑

MDT

100.05

+3%↑

A

146.51

+3.24%↑

VEEV

236.48

+6.28%↑

HQY

95.71

+1.86%↑

PHR.US

17.15

+0.06%↑

Search

KemPharm Inc

Open

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-75M

-544K

Sales

182K

26M

P/E

Sector Avg

18.766

88.032

Profit margin

-2.087

Employees

59

EBITDA

73M

1.5M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+187.77% upside

Market Stats

By TradingEconomics

Market Cap

-77M

497M

Previous open

0

Previous close

0

KemPharm Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 lut 2025, 15:29 UTC

Acquisitions, Mergers, Takeovers

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million

Peer Comparison

Price change

KemPharm Inc Forecast

Price Target

By TipRanks

187.77% upside

12 Months Forecast

Average 24 USD  187.77%

High 26 USD

Low 21 USD

Based on 6 Wall Street analysts offering 12 month price targets forKemPharm Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat